全文获取类型
收费全文 | 8024篇 |
免费 | 438篇 |
国内免费 | 57篇 |
专业分类
耳鼻咽喉 | 89篇 |
儿科学 | 179篇 |
妇产科学 | 211篇 |
基础医学 | 1105篇 |
口腔科学 | 164篇 |
临床医学 | 713篇 |
内科学 | 2018篇 |
皮肤病学 | 98篇 |
神经病学 | 763篇 |
特种医学 | 208篇 |
外科学 | 1383篇 |
综合类 | 46篇 |
一般理论 | 2篇 |
预防医学 | 263篇 |
眼科学 | 112篇 |
药学 | 467篇 |
1篇 | |
中国医学 | 13篇 |
肿瘤学 | 684篇 |
出版年
2024年 | 8篇 |
2023年 | 75篇 |
2022年 | 131篇 |
2021年 | 256篇 |
2020年 | 149篇 |
2019年 | 204篇 |
2018年 | 198篇 |
2017年 | 128篇 |
2016年 | 197篇 |
2015年 | 248篇 |
2014年 | 358篇 |
2013年 | 377篇 |
2012年 | 587篇 |
2011年 | 622篇 |
2010年 | 365篇 |
2009年 | 299篇 |
2008年 | 555篇 |
2007年 | 616篇 |
2006年 | 519篇 |
2005年 | 496篇 |
2004年 | 474篇 |
2003年 | 421篇 |
2002年 | 356篇 |
2001年 | 57篇 |
2000年 | 37篇 |
1999年 | 69篇 |
1998年 | 78篇 |
1997年 | 64篇 |
1996年 | 60篇 |
1995年 | 61篇 |
1994年 | 57篇 |
1993年 | 45篇 |
1992年 | 39篇 |
1991年 | 35篇 |
1990年 | 23篇 |
1989年 | 22篇 |
1988年 | 11篇 |
1987年 | 18篇 |
1986年 | 23篇 |
1985年 | 21篇 |
1984年 | 22篇 |
1983年 | 18篇 |
1982年 | 16篇 |
1981年 | 12篇 |
1980年 | 11篇 |
1977年 | 5篇 |
1975年 | 9篇 |
1974年 | 5篇 |
1966年 | 5篇 |
1908年 | 5篇 |
排序方式: 共有8519条查询结果,搜索用时 15 毫秒
991.
Salvarani C Casali B Farnetti E Pipitone N Nicoli D Macchioni P Cimino L Bajocchi G Catanoso MG Boiardi L 《The Journal of rheumatology》2005,32(11):2173-2177
OBJECTIVE: To investigate potential associations between the -174 G/C interleukin-6 (IL-6) promoter polymorphism and susceptibility to and clinical features of giant cell arteritis (GCA), particularly in patients with or without polymyalgia rheumatica (PMR) and with or without ischemic complications. METHODS: One hundred and twenty-six patients with biopsy-proven GCA who were residents in Reggio Emilia, Italy, and 112 population-based controls from the same geographic area were genotyped for IL-6 polymorphism at position -174 by molecular methods. Patients were divided in subgroups according to presence or absence of PMR and ischemic complications (visual loss, jaw claudication, cerebrovascular accidents, aortic arch syndrome). RESULTS: Distribution of the G/C 174 genotype was similar in patients with GCA and controls. No significant associations with the IL-6 promoter polymorphism at position -174 were found when GCA patients with or without PMR or with or without ischemic complications were compared. Further, IL-6 genotypes did not significantly affect levels of C-reactive protein or other inflammatory markers at diagnosis. CONCLUSION: Our findings show that the 174 G/C promoter IL-6 polymorphism does not seem to be implicated in susceptibility to and clinical expression of GCA. 相似文献
992.
Pignata S Breda E Scambia G Pisano C Zagonel V Lorusso D Greggi S De Vivo R Ferrandina G Gallo C Perrone F 《Critical reviews in oncology/hematology》2008,66(3):229-236
BACKGROUND: Carboplatin/paclitaxel every 3 weeks is the standard for patients with ovarian cancer, but elderly patients frequently receive modified schedules or single agent chemotherapy to avoid toxicity. A phase II study was conducted to describe tolerability of a weekly schedule of both drugs in elderly patients. METHODS: Patients aged>or=70 years with stage IC-IV ovarian cancer, performance status相似文献
993.
Puggioni E Brignole M Gammage M Soldati E Bongiorni MG Simantirakis EN Vardas P Gadler F Bergfeldt L Tomasi C Musso G Gasparini G Del Rosso A 《Journal of the American College of Cardiology》2004,43(2):234-238
We tested the hypothesis that left ventricular (LV) pacing is superior to right ventricular (RV) apical pacing in patients undergoing atrioventricular (AV) junction ablation and pacing for permanent atrial fibrillation.The potential benefit of LV over RV pacing needs to be evaluated without the confounding effect of other variables that can influence cardiac performance.An acute intrapatient comparison of the QRS width and echocardiographic parameters between RV versus LV pacing was performed within 24 h after ablation in 44 patients. Both modes of pacing were also compared with pre-implantation values.Compared with RV pacing, LV pacing caused a 5.7% increase in the ejection fraction (EF) and a 16.7% decrease in the mitral regurgitation (MR) score; the QRS width was 4.8% shorter with LV pacing. Similar results were observed in patients with or without systolic dysfunction and/or native left bundle branch block, except for a greater improvement in MR in the latter group. Compared with pre-ablation measures, the EF increased by 11.2% and 17.6% with RV and LV pacing, respectively; the MR score decreased by 0% and 16.7%; and the diastolic filling time increased by 12.7% and 15.6%.Rhythm regularization achieved with AV junction ablation improved EF with both RV and LV pacing; LV pacing provided an additional modest but favorable hemodynamic effect, as reflected by a further increase of EF and reduction of MR. The effect seems to be equal in patients with both depressed and preserved systolic functions and in those with and without native left bundle branch block. 相似文献
994.
Godino C Furuichi S Latib A Morici N Chieffo A Romagnoli E Tamburino C Barbagallo R Cera M Antoniucci D Goktekin O Di Mario C Reimers B Grube E Airoldi F Sangiorgi GM Colombo A 《The American journal of cardiology》2008,102(8):1002-1008
Several randomized trials have shown that sirolimus-eluting stents and paclitaxel-eluting stents (PES) are effective in reducing restenosis in respect to bare-metal stents, including the subset of small vessels. The objective of this study was to evaluate "real world" angiographic and clinical outcomes of a large series of patients enrolled in the TRUE registry and treated with PES for both small vessel and very small vessel lesions. A consecutive series of 675 patients (926 lesions) with reference vessel diameter <2.75 mm measured by quantitative coronary angiography analysis were analyzed. The primary end point was the rate of angiographic in-stent restenosis and 1-year major adverse cardiac events. In this study 390 lesions were identified as small vessel (reference vessel diameter >or=2.25 and <2.75 mm) and 536 lesions as very small vessel (reference vessel diameter <2.25 mm). Overall in-stent restenosis was 15.5% (n = 96). Compared with small vessel, the very small vessel lesions had more in-stent restenosis (21.7% vs 11.4%, p <0.001) and in-segment restenosis (29.3% vs 22.5%, p = 0.055). The majority of the restenotic lesions (n = 125) were focal (57%, n = 71). At 1 year, cardiac death was 1.6% (n = 11), acute myocardial infarction 0.5% (n = 4.), and the target lesion revascularization 12.8% (n = 86). Cumulative major adverse cardiac events rate was 17.3% (n = 119). The rate of definite and probable stent thrombosis was 0.9% (n = 8). In conclusion, in comparison with historical bare-metal stent controls, this large series of small vessel lesions treated with PES confirms previous results reporting the efficacy of PES in small vessels. The rate of subacute and late stent thrombosis was low in this subgroup of patients. 相似文献
995.
Carlo Lanza Gisella Volpe Giuseppe Basso Enrico Gottardi Elena Barisone Monica Spinelli Emanuela Ricotti Vania Cilli Fatima Perfetto Enrico Madon & Giuseppe Saglio 《British journal of haematology》1997,97(2):460-462
The t(12;21)(p13;q22) translocation has been described recently as the most recurrent genetic lesion in paediatric acute lymphoblastic leukaemias (ALLs). It has also been associated with B-precursor lineage involvement and good outcome.
We tested 51 diagnostic paediatric ALLs and found 11 cases with molecular evidence of the t(12;21). Interestingly, amongst t(12;21) positive patients, we report three cases with hybrid phenotype, and two cases showing an aggressive and fatal disease. Our data show that the t(12;21) does not represent an independent good-risk indicator. Long follow-ups and additional molecular investigations are needed to assess the prognostic and pathogenetic relevance of t(12;21) in childhood ALLs. 相似文献
We tested 51 diagnostic paediatric ALLs and found 11 cases with molecular evidence of the t(12;21). Interestingly, amongst t(12;21) positive patients, we report three cases with hybrid phenotype, and two cases showing an aggressive and fatal disease. Our data show that the t(12;21) does not represent an independent good-risk indicator. Long follow-ups and additional molecular investigations are needed to assess the prognostic and pathogenetic relevance of t(12;21) in childhood ALLs. 相似文献
996.
3‐Year Randomized Controlled Prospective Clinical Trial on Different CAD‐CAM Implant Abutments 下载免费PDF全文
997.
Fabrizio Bar Stefania Battista Enrico Garello Maurizio Grosso Francesco Spalluto Eugenio Zanon Mauro Torchio Gianpaolo Molino 《Liver international》1998,18(4):245-250
ABSTRACT— Aims/Background: TIPS, an effective procedure applied for the treatment of complications of portal hypertension, is potentially followed by worsening of the hyperdynamic circulation of cirrhosis and the impairment of liver function. The aim of the present study was to evaluate short-term changes of functional liver plasma flow after application of TIPS, using the hepatic (extrarenal) clearance of D-sorbitol (S-HCl). Methods: Twenty-five cirrhotic patients submitted to TIPS for prevention of variceal rebleeding entered the study. At steady-state, during constant infusion of a solution of D-sorbitol (25 mg/min), appropriate blood and urine samples were collected in order to calculate S-HCl before and 120 min after TIPS opening. In addition, the hepatic extraction ratio of D-sorbitol was directly measured at the level of the right (Er), where TIPS was applied, and of the left (El) hepatic veins; meanwhile the portocaval gradient (PCG) was registered, before and after stent dilation. A comparison of values obtained before and after TIPS application was performed by Student's t-test for paired data. Results: After application of TIPS, a substantial reduction was observed in PCG (12.1 ± 4.2 vs 24.8 ± 4.3 mmHg; p<0.001) and Er values (20.6 ± 14.8 vs 57.5 ± 22.3%; p<0.001) but not El values (47.4 ± 22.0 vs 53.4 ± 21.4%; p=0.178). S-HCl measured 120 min after TIPS opening was not statistically different from pre-TIPS values (389.2 ± 212.1 vs 394.6 ± 152.7 ml/min; p=0.892), although S-HCl variations in Child-Pugh class B patients were positively correlated with portal pressure variations (r=0.63, p=0.016). Conclusion: Our results demonstrate that in patients with advanced cirrhosis, TIPS procedure, while effective in reducing portal hypertension, does not lead to alterations in the functional liver plasma flow within the first 2 h. 相似文献
998.
Gabriele Bassi Peter Radermacher Enrico Calzia 《Endocrinology & Metabolism Clinics of North America》2006,35(4):839-57, x
This article summarizes the effects of catecholamines and vasopressin on the cardiovascular system, focusing on their metabolic and immunologic properties. Particular attention is dedicated to the septic shock condition. 相似文献
999.
Palomba S Orio F Falbo A Manguso F Russo T Cascella T Tolino A Carmina E Colao A Zullo F 《The Journal of clinical endocrinology and metabolism》2005,90(7):4068-4074
CONTEXT: Although metformin has been shown to be effective in the treatment of anovulation in women with polycystic ovary syndrome (PCOS), clomiphene citrate (CC) is still considered to be the first-line drug to induce ovulation in these patients. OBJECTIVE: The goal of this study was to compare the effectiveness of metformin and CC administration as a first-line treatment in anovulatory women with PCOS. DESIGN: We describe a prospective parallel randomized, double-blind, double-dummy controlled clinical trial. SETTING: The study was conducted at the University "Magna Graecia" of Catanzaro, Catanzaro, Italy. PATIENTS: One hundred nonobese primary infertile anovulatory women with PCOS participated. INTERVENTIONS: We administered metformin cloridrate (850 mg twice daily) plus placebo (group A) or placebo plus CC (150 mg for 5 d from the third day of a progesterone withdrawal bleeding) (group B) for 6 months each. MEAN OUTCOME MEASURES: The main outcome measures were ovulation, pregnancy, abortion, and live-birth rates. RESULTS: The subjects of groups A (n = 45) and B (n = 47) were studied for a total of 205 and 221 cycles, respectively. The ovulation rate was not statistically different between either treatment group (62.9 vs. 67.0%, P = 0.38), whereas the pregnancy rate was significantly higher in group A than group B (15.1 vs. 7.2%, P = 0.009). The difference found between groups A and B regarding the abortion rate was significant (9.7 vs. 37.5%, P = 0.045), whereas a positive trend was observed for the live-birth rate (83.9 vs. 56.3%, P = 0.07). The cumulative pregnancy rate was significantly higher in group A than group B (68.9 vs. 34.0%, P < 0.001). CONCLUSIONS: Six-month metformin administration is significantly more effective than six-cycle CC treatment in improving fertility in anovulatory nonobese PCOS women. 相似文献
1000.
Mario Di Gioacchino Fabio Di Stefano Enrico Cavallucci Nicola Verna Stefania Ramondo Franco Paolini Riccardo Caruso Cosima Schiavone Silvio Masci Bartolomeo Santucci Roberto Paganelli Pio Conti 《Allergy and asthma proceedings》2003,24(4):285-290
This study evaluates the effectiveness and safety of cyclosporine (CsA) in the treatment of patients with chronic idiopathic urticaria with a positive autologous serum skin test (ASST), who fail to respond to conventional therapy, and requiring long-term oral steroid treatment. In a double-blind study, 40 adults were assigned randomly to receive CsA (5 mg/kg per day for 8 weeks and then 4 mg/kg per day for 8 weeks) or cetirizine (10 mg/day) and then they were followed up for 9 months. After 2 weeks, the study was opened because 16 patients (40%) had daily severe relapses requiring systemic steroids treatment. All of these patients had been receiving antihistamines and, therefore, all patients also were assigned to the CsA treatment regimen (5 mg/kg per day for 8 weeks and then 4 mg/kg per day for 8 weeks). The ASST and clinical severity score were evaluated before and after treatment. All of the 40 patients completed the 16-week CsA course without dropping out because of relevant side effects. In three patients, CsA was reduced by 0.5 mg/kg per day after the 1st month of treatment for a mild and reversible increase in serum creatinine. During CsA treatment, 20 patients had relapses resolving spontaneously (8 patients) or with antihistamines (12 patients). During the 9-month follow-up period, 22 patients had relapses resolving spontaneously (10 patients) or with antihistamines (12 patients). Only two patients failed to complete the study because of severe symptoms occurring after 4 and 7 days of follow-up and requiring long-term steroid treatment. After 9 months of follow-up, 16 patients were still in full remission. The clinical severity score of chronic idiopathic urticaria dropped significantly by the end of the 4th month of treatment (p = 0.002) as well as by the completion of follow-up (p = 0.007). The ASST was negative in 13 patients and positive in 3 of 16 patients, with total remission of symptoms. Significant score reduction also was observed in patients experiencing relapses that resolved spontaneously (p = 0.005) or with antihistamines (p = 0.03). These results show the long-term efficacy and tolerability of CsA in patients with severe chronic idiopathic urticaria, unresponsive to conventional treatments. 相似文献